Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkins lymphoma (NHL), and multiple myeloma transplantation models.Ulocplumab inhibits the migration of chron
Molecular Weight:
146.2 (kDa)
CAS Number:
[1375830-34-4]
Target:
CXCR|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted